Mind Medicine (MindMed) Inc. (E:MMED*CA)

Business Focus: Biotechnology & Medical Research (NEC)

Sector:  Healthcare Industry:  Biotechnology & Medical Research
See Regulatory Filings on SEDAR
Company Contact
Address: 1166 Alberni Steet, Suite 1604
Tel: N/A
Website: https://mindmed.co
IR: See website
Key People
Miriam Halperin Wernli
Executive President, Director
Robert Barrow
Chief Executive Officer, Director
Daniel R. Karlin
Chief Medical Officer
Francois Lilienthal
Chief Commercial Officer
Cynthia Wong Hu
Corporate Secretary, Chief Legal Officer
Business Overview
Mind Medicine (MindMed) Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. The Company is developing a pipeline of drug candidates, targeting the serotonin, dopamine and acetylcholine systems. This specifically includes pharmaceutically optimized drug products derived from the psychedelic and empathogen drug classes, including lysergic acid diethylamide (LSD), R(-)-methylenedioxymethamphetamine (MDMA) and zolunicant, or 18-methoxycoronaridine (MC), a congener of ibogaine. The Company's subsidiaries include Mind Medicine, Inc. (MindMed US), HealthMode, Inc., MindMed Pty Ltd., and MindMed GmbH.
Financial Overview
For the fiscal year ended 31 December 2021, Mind Medicine (MindMed) Inc revenues was not reported. Net loss increased from $33.9M to $93M. Higher net loss reflects Stock based compensation increase from $6.9M to $35.5M (expense), General and administrative - Balancing v increase from $7.5M to $23.5M (expense), Research and development - Balancing val increase of 53% to $27.6M (expense).
Reporting Currency:
Enterprise value: $251.03M as of Mar 31, 2022
Annual revenue (TTM): N/A
Net annual income (TTM): N/A
Free cash flow (TTM): N/A
Net Debt Last Fiscal Year: N/A
Shares outstanding: N/A
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.